However, this effect was limited (Fig. 7b–d), indicating that blocking β-adrenergic receptor–mediated adipocyte browning or FFA uptake by tumor cells could effectively enhance the therapeutic efficiency of oxaliplatin in the treatment of MIIP-aberrant CRC. The gene discussed is MIIP; the disease is colorectal carcinoma.